UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interventions to improve the appropriate use of polypharmacy for older people

Cochrane database of systematic reviews, 2014-10 (10), p.CD008165-CD008165

2014

Volltextzugriff (PDF)

Interventions to improve the appropriate use of polypharmacy for older people

Cochrane database of systematic reviews, 2012-05 (5), p.CD008165

2012

Volltextzugriff (PDF)

Interventions to improve the appropriate use of polypharmacy for older people

Cochrane database of systematic reviews, 2018-09, Vol.9 (9), p.CD008165

2018

Volltextzugriff (PDF)

Effectiveness of a Multifaceted Intervention for Potentially Inappropriate Prescribing in Older Patients in Primary Care: A Cluster-Randomized Controlled Trial (OPTI-SCRIPT Study)

Annals of family medicine, 2015-11, Vol.13 (6), p.545-553

2015

Volltextzugriff (PDF)

Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic

PloS one, 2022-09, Vol.17 (9), p.e0267815

2022

Volltextzugriff (PDF)

Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study

BMJ open, 2023-04, Vol.13 (4), p.e070985-e070985

2023

Volltextzugriff (PDF)

Electronic Prescribing and Other Forms of Technology to Reduce Inappropriate Medication Use and Polypharmacy in Older People: A Review of Current Evidence

Clinics in geriatric medicine, 2012-05, Vol.28 (2), p.301-322

2012

Volltextzugriff (PDF)

Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people

Cochrane database of systematic reviews, 2013-11, Vol.2013 (11), p.CD006354-CD006354

2013

Volltextzugriff (PDF)

Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety

Annals of epidemiology, 2016-11, Vol.26 (11), p.735-740

2016

Volltextzugriff (PDF)

Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin

JAMA internal medicine, 2021-05, Vol.181 (5), p.598

2021

Volltextzugriff (PDF)

Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes

Age and ageing, 2021-03, Vol.50 (2), p.457-464

2021

Volltextzugriff (PDF)

A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus

Cancer epidemiology, biomarkers & prevention, 2018-05, Vol.27 (5), p.525-530

2018

Volltextzugriff (PDF)

Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database

European journal of clinical pharmacology, 2012-10, Vol.68 (10), p.1425-1433

2012

Volltextzugriff (PDF)

Potentially inappropriate prescribing among older people in the United Kingdom

BMC geriatrics, 2014-06, Vol.14 (1), p.72-72, Article 72

2014

Volltextzugriff (PDF)

Testosterone therapy and cancer risks among men in the SEER-Medicare linked database

British journal of cancer, 2023-01, Vol.128 (1), p.48-56

2023

Volltextzugriff (PDF)

Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding

The Journal of asthma, 2024-07, Vol.61 (7), p.1-662

2024

Volltextzugriff (PDF)

Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Cancer, 2016-07, Vol.122 (13), p.2067-2075

2016

Volltextzugriff (PDF)

Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink

European journal of epidemiology, 2019-09, Vol.34 (9), p.871-878

2019

Volltextzugriff (PDF)

Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark

Pharmacoepidemiology and drug safety, 2024-09, Vol.33 (9), p.e5849-n/a

2024

Volltextzugriff (PDF)

A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions

Pharmacoepidemiology and drug safety, 2023-03, Vol.32 (3), p.298-311

2023

Volltextzugriff (PDF)

Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins

Diabetes care, 2020-04, Vol.43 (4), p.785-792

2020

Volltextzugriff (PDF)

Categorization of COVID‐19 severity to determine mortality risk

Pharmacoepidemiology and drug safety, 2022-07, Vol.31 (7), p.721-728

2022

Volltextzugriff (PDF)

The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making

JCO clinical cancer informatics, 2024-01, Vol.8 (8), p.e2300261

2024

Volltextzugriff (PDF)

Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study)

BMC health services research, 2013-08, Vol.13 (1), p.307-307, Article 307

2013

Volltextzugriff (PDF)

Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

Cancer causes & control, 2018-08, Vol.29 (8), p.785-791

2018

Volltextzugriff (PDF)

1 – 25 von 451

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(424)
Mit Volltextzugriff
(365)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Interventions to improve the appropriate use of polypharmacy for older people

Interventions to improve the appropriate use of polypharmacy for older people

Interventions to improve the appropriate use of polypharmacy for older people

Effectiveness of a Multifaceted Intervention for Potentially Inappropriate Prescribing in Older Patients in Primary Care: A Cluster-Randomized Controlled Trial (OPTI-SCRIPT Study)

Describing characteristics and treatment patterns of patients hospitalized with COVID-19 by race and ethnicity in a national RWD during the early months of the pandemic

Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study

Electronic Prescribing and Other Forms of Technology to Reduce Inappropriate Medication Use and Polypharmacy in Older People: A Review of Current Evidence

Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people

Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety

Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin

Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes

A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus

Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database

Potentially inappropriate prescribing among older people in the United Kingdom

Testosterone therapy and cancer risks among men in the SEER-Medicare linked database

Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding

Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink

Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark

A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions

Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins

Categorization of COVID‐19 severity to determine mortality risk

The Bar Is High: Evaluating Fit-for-Use Oncology Real-World Data for Regulatory Decision Making

Addressing potentially inappropriate prescribing in older patients: development and pilot study of an intervention in primary care (the OPTI-SCRIPT study)

Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer

Suchergebnisse filtern